TYR and melanoma: This is comparable with earlier reports, where a recombinant Ad expressing β-Gal under the control of two copies of the mouse tyrosinase enhancer in combination with a 770 bp mouse tyrosinase promoter gave rise to 100- to 200-fold higher expression in melanoma cells compared to non-melanoma cells [57].